30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Hyperion DeFi Inc (HYPD)

Track

Over the last 90 days, Hyperion DeFi Inc. saw insider buying totaling $29,580, with one executive making net purchases. This activity represents a small fraction of the company's float. Recent transactions show consistent buying from multiple insiders, including the Chief Financial Officer, over the past year.
Stock chart
Ticker: HYPD Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Jung Hyunsu
See Remarks
2 purchases — total 200,000 USD
Buy 2 Jun 2026
Value US$4,035,253.71 | Price 107.27 | Shares 73,894
Buy 2 Jun 2026
Value US$438,902.00 | Price 243.39 | Shares 28,430
Buy 1 Jun 2026
Value US$1,846,272.27 | Price 18.22 | Shares 80,553
Buy 1 Jun 2026
Value US$2,639,008.41 | Price 110.49 | Shares 92,505
Buy 31 Dec 2025
Value US$100,340.50 | Price 3.59 | Shares 27,950
Buy 29 Dec 2025
Value US$42,800.16 | Price 3.61 | Shares 11,856
Buy 29 Dec 2025
Value US$43,603.20 | Price 3.60 | Shares 12,112
Buy 26 Dec 2025
Value US$12,777.15 | Price 3.86 | Shares 3,311
Buy 26 Dec 2025
Value US$13,910.66 | Price 3.86 | Shares 3,601
Buy 18 Dec 2025
Value US$61,834.73 | Price 3.14 | Shares 19,702
Buy 18 Dec 2025
Value US$58,829.26 | Price 3.14 | Shares 18,742
Buy 17 Dec 2025
Value US$187,152.46 | Price 3.02 | Shares 61,930
Buy 17 Dec 2025
Value US$90,210.00 | Price 3.01 | Shares 30,000
Proposed sale 22 Jul 2025
Value US$17,515.00 | Price 12.86 | Shares 1,362
Buy 28 Aug 2024
Value US$14,076.92 | Price 0.52 | Shares 27,071
Buy 26 Aug 2024
Value US$28,500.00 | Price 0.57 | Shares 50,000
Buy 2 Jul 2024
Value US$999,999.66 | Price 0.66 | Shares 1,515,151
Buy 28 Mar 2024
Value US$98,000.00 | Price 0.98 | Shares 100,000
Buy 19 Mar 2024
Value US$61,500.00 | Price 1.23 | Shares 50,000
Buy 8 Mar 2024
Value US$16,911.43 | Price 1.58 | Shares 10,717
Buy 4 Dec 2023
Value US$6,650.40 | Price 1.36 | Shares 4,890
Buy 29 Sep 2023
Value US$8,097.60 | Price 1.68 | Shares 4,820
Buy 19 Sep 2023
Value US$2,324.00 | Price 1.66 | Shares 1,400
Buy 15 Sep 2023
Value US$1,989.75 | Price 1.75 | Shares 1,137
Buy 17 Aug 2023
Value US$56,100.00 | Price 1.87 | Shares 30,000
Buy 16 Aug 2023
Value US$85,815.00 | Price 1.91 | Shares 45,000
Buy 31 May 2023
Value US$5,580.00 | Price 2.79 | Shares 2,000
Buy 26 May 2023
Value US$6,825.00 | Price 2.73 | Shares 2,500
Buy 26 May 2023
Value US$7,469.70 | Price 2.49 | Shares 3,000
Buy 25 May 2023
Value US$233,854.55 | Price 2.65 | Shares 88,247
Buy 23 May 2023
Value US$30,976.00 | Price 3.10 | Shares 10,000
Sale 1 May 2023
Value US$495,000.00 | Price 5.50 | Shares 90,000
Proposed sale 1 May 2023
Value US$495,000.00 | Price 5.50 | Shares 90,000
Sale 27 Apr 2023
Value US$300,000.00 | Price 5.00 | Shares 60,000
Proposed sale 27 Apr 2023
Value US$300,000.00 | Price 5.00 | Shares 60,000
Planned sale 14 Apr 2023
Value US$180,000.00 | Price 4.50 | Shares 40,000
Proposed sale 14 Apr 2023
Value US$180,000.00 | Price 4.50 | Shares 40,000
Planned sale 11 Apr 2023
Value US$160,000.00 | Price 4.00 | Shares 40,000
Planned sale 31 Mar 2023
Value US$140,000.00 | Price 3.50 | Shares 40,000
Buy 30 Dec 2022
Value US$15,400.00 | Price 1.54 | Shares 10,000
Buy 30 Dec 2022
Value US$32,629.50 | Price 1.50 | Shares 21,753
Buy 31 Aug 2022
Value US$10,805.24 | Price 1.62 | Shares 6,686
Buy 30 Aug 2022
Value US$10,802.54 | Price 1.60 | Shares 6,744
Buy 29 Aug 2022
Value US$12,837.91 | Price 1.62 | Shares 7,931
Buy 24 Aug 2022
Value US$2,384.29 | Price 1.59 | Shares 1,504
Buy 21 Jun 2022
Value US$165,000.00 | Price 1.65 | Shares 100,000
Buy 19 May 2022
Value US$22,000.00 | Price 2.20 | Shares 10,000
Buy 18 May 2022
Value US$14,231.70 | Price 2.03 | Shares 7,000
Buy 11 May 2022
Value US$48,750.00 | Price 1.95 | Shares 25,000
Buy 10 May 2022
Value US$99,000.00 | Price 1.98 | Shares 50,000
Buy 5 May 2022
Value US$58,592.76 | Price 2.26 | Shares 25,926
Buy 4 May 2022
Value US$54,407.24 | Price 2.26 | Shares 24,074
Buy 22 Apr 2022
Value US$51,000.00 | Price 2.55 | Shares 20,000
Buy 21 Apr 2022
Value US$100,492.00 | Price 2.59 | Shares 38,800
Buy 22 Feb 2022
Value US$115,500.00 | Price 2.75 | Shares 42,000
Buy 18 Feb 2022
Value US$28,500.00 | Price 2.85 | Shares 10,000
Buy 7 Feb 2022
Value US$107,009.10 | Price 2.97 | Shares 36,030
Buy 15 Dec 2021
Value US$345,000.00 | Price 3.45 | Shares 100,000
Buy 16 Nov 2021
Value US$88,000.00 | Price 3.52 | Shares 25,000
Buy 15 Nov 2021
Value US$91,750.00 | Price 3.67 | Shares 25,000
Buy 15 Nov 2021
Value US$91,000.00 | Price 3.64 | Shares 25,000
Buy 15 Nov 2021
Value US$90,000.00 | Price 3.60 | Shares 25,000
Buy 3 Nov 2021
Value US$121,206.00 | Price 4.04 | Shares 30,000
Buy 1 Nov 2021
Value US$15,314.40 | Price 3.83 | Shares 4,000
Buy 29 Oct 2021
Value US$56,643.75 | Price 3.75 | Shares 15,105
Buy 29 Oct 2021
Value US$1,496.00 | Price 3.74 | Shares 400
Buy 27 Oct 2021
Value US$4,968.00 | Price 4.14 | Shares 1,200
Buy 26 Oct 2021
Value US$400,000.00 | Price 4.00 | Shares 100,000
Buy 25 Oct 2021
Value US$135,224.00 | Price 4.00 | Shares 33,806
Buy 13 Sep 2021
Value US$6,600.00 | Price 4.40 | Shares 1,500
Buy 15 Jun 2021
Value US$10,812.00 | Price 5.41 | Shares 2,000
Buy 14 Jun 2021
Value US$10,940.00 | Price 5.47 | Shares 2,000
Buy 11 Jun 2021
Value US$10,760.00 | Price 5.38 | Shares 2,000
Buy 28 May 2021
Value US$14,268.30 | Price 4.76 | Shares 3,000
Buy 27 May 2021
Value US$6,594.00 | Price 4.71 | Shares 1,400
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-02 2026-06-02 B Purchase
Jung Hyunsu

See Remarks

Executive Director
73,894 +40.2%
107.27
US$4,035,254 		73,894 +40.2% 107.27 US$4,035,254
2026-06-02 2026-06-02 B Purchase
Jung Hyunsu

See Remarks

Executive Director
28,430 +37.1%
243.39
US$438,902 		28,430 +37.1% 243.39 US$438,902
2026-06-02 2026-06-01 B Purchase
Jung Hyunsu

See Remarks

Executive Director
80,553 +32.3%
18.22
US$1,846,272 		80,553 +32.3% 18.22 US$1,846,272
2026-06-02 2026-06-01 B Purchase
Jung Hyunsu

See Remarks

Executive Director
1,000 +0.4%
3.66
US$100,000 		1,000 +0.4% 3.66 US$100,000
2026-01-05 2025-12-31 B Purchase
1.7
Knox David R.

Chief Financial Officer

Officer
27,950 +9.3%
3.59
US$100,340 		27,950 +9.3% 3.59 US$100,340
2025-12-30 2025-12-29 B Purchase
3.0
Strahlman Ellen R
Non-Executive Director
11,856 +51.5%
3.61
US$42,800 		11,856 +51.5% 3.61 US$42,800
2025-12-30 2025-12-29 B Purchase
3.0
Strahlman Ellen R
Non-Executive Director
12,112 +15.3%
3.60
US$43,603 		12,112 +15.3% 3.60 US$43,603
2025-12-30 2025-12-26 B Purchase
3.0
Strahlman Ellen R
Non-Executive Director
3,311 +16.8%
3.86
US$12,777 		3,311 +16.8% 3.86 US$12,777
2025-12-30 2025-12-26 B Purchase
3.0
Strahlman Ellen R
Non-Executive Director
3,601 +4.8%
3.86
US$13,911 		3,601 +4.8% 3.86 US$13,911
2025-12-22 2025-12-18 B Purchase
3.0
Strahlman Ellen R
Non-Executive Director
19,702 +26.1%
3.14
US$61,835 		19,702 +26.1% 3.14 US$61,835
2025-12-22 2025-12-18 B Purchase
3.0
Strahlman Ellen R
Non-Executive Director
18,742 +33.1%
3.14
US$58,829 		18,742 +33.1% 3.14 US$58,829
2025-12-19 2025-12-17 B Purchase
3.4
Walters Happy David
Non-Executive Director
61,930 +123.9%
3.02
US$187,152 		61,930 +123.9% 3.02 US$187,152
2025-12-19 2025-12-17 B Purchase
3.2
GELTZEILER MICHAEL S
Non-Executive Director
30,000 +51.7%
3.01
US$90,210 		30,000 +51.7% 3.01 US$90,210
2025-07-22 2025-07-22 PrS Proposed sale
2.2
MATHER CHARLES E IV

Director

Non-Executive Director
1,362
12.86
US$17,515 		1,362 12.86 US$17,515
2024-08-28 2024-08-28 B Purchase
2.8
Rowe Michael M

Chief Executive Officer

Executive Director
27,071 +32.6%
0.52
US$14,077 		27,071 +32.6% 0.52 US$14,077
2024-08-27 2024-08-26 B Purchase
2.8
Rowe Michael M

Chief Executive Officer

Executive Director
50,000 +151.9%
0.57
US$28,500 		50,000 +151.9% 0.57 US$28,500
2024-07-03 2024-07-02 B Purchase
3.8
Grant Stuart M.
Large shareholder
1,515,151 +16.1%
0.66
US$1,000,000 		1,515,151 +16.1% 0.66 US$1,000,000
2024-03-28 2024-03-28 B Purchase
3.8
Grant Stuart M.
Large shareholder
100,000 +1.9%
0.98
US$98,000 		100,000 +1.9% 0.98 US$98,000
2024-03-20 2024-03-19 B Purchase
3.8
Grant Stuart M.
Large shareholder
50,000 +0.9%
1.23
US$61,500 		50,000 +0.9% 1.23 US$61,500
2024-03-11 2024-03-08 B Purchase
3.8
Grant Stuart M.
Large shareholder
10,717 +0.2%
1.58
US$16,911 		10,717 +0.2% 1.58 US$16,911
2023-12-05 2023-12-04 B Purchase
2.8
Rowe Michael M

Chief Executive Officer

Executive Director
4,890 +17.4%
1.36
US$6,650 		4,890 +17.4% 1.36 US$6,650
2023-10-02 2023-09-29 B Purchase
3.0
Strahlman Ellen R
Non-Executive Director
4,820 +6.9%
1.68
US$8,098 		4,820 +6.9% 1.68 US$8,098
2023-09-19 2023-09-19 B Purchase
2.8
Rowe Michael M

Chief Executive Officer

Executive Director
1,400 +5.3%
1.66
US$2,324 		1,400 +5.3% 1.66 US$2,324
2023-09-19 2023-09-15 B Purchase
2.8
Rowe Michael M

Chief Executive Officer

Executive Director
1,137 +4.5%
1.75
US$1,990 		1,137 +4.5% 1.75 US$1,990
2023-08-17 2023-08-17 B Purchase
3.8
Grant Stuart M.
Large shareholder
30,000 +0.6%
1.87
US$56,100 		30,000 +0.6% 1.87 US$56,100
2023-08-17 2023-08-16 B Purchase
3.8
Grant Stuart M.
Large shareholder
45,000 +0.9%
1.91
US$85,815 		45,000 +0.9% 1.91 US$85,815
2023-05-31 2023-05-31 B Purchase
3.8
GANDOLFO JOHN P

Chief Financial Officer

Officer
2,000 +33.3%
2.79
US$5,580 		2,000 +33.3% 2.79 US$5,580
2023-05-31 2023-05-26 B Purchase
0.6
Kern Bren

Chief Operating Officer

Officer
2,500 +inf%
2.73
US$6,825 		2,500 +inf% 2.73 US$6,825
2023-05-30 2023-05-26 B Purchase
2.2
MATHER CHARLES E IV
Non-Executive Director
3,000 +4.0%
2.49
US$7,470 		3,000 +4.0% 2.49 US$7,470
2023-05-26 2023-05-25 B Purchase
3.8
Grant Stuart M.
Large shareholder
88,247 +1.7%
2.65
US$233,855 		88,247 +1.7% 2.65 US$233,855
2023-05-25 2023-05-23 B Purchase
3.0
Strahlman Ellen R
Non-Executive Director
10,000 +23.2%
3.10
US$30,976 		10,000 +23.2% 3.10 US$30,976
2023-05-02 2023-05-01 S Sale
3.7
Ianchulev Tsontcho
Non-Executive Director
90,000 -21.4%
5.50
US$495,000 		90,000 -21.4% 5.50 US$495,000
2023-05-01 2023-05-01 PrS Proposed sale
3.7
Ianchulev Tsontcho

Officer

Officer
90,000
5.50
US$495,000 		90,000 5.50 US$495,000
2023-05-01 2023-04-27 S Sale
3.7
Ianchulev Tsontcho
Non-Executive Director
60,000 -12.5%
5.00
US$300,000 		60,000 -12.5% 5.00 US$300,000
2023-04-27 2023-04-27 PrS Proposed sale
3.7
Ianchulev Tsontcho

Officer

Officer
60,000
5.00
US$300,000 		60,000 5.00 US$300,000
2023-04-17 2023-04-14 PlS Planned sale
3.7
Ianchulev Tsontcho
Non-Executive Director
40,000 -7.7%
4.50
US$180,000 		40,000 -7.7% 4.50 US$180,000
2023-04-14 2023-04-14 PrS Proposed sale
3.7
Ianchulev Tsontcho

Officer

Officer
40,000
4.50
US$180,000 		40,000 4.50 US$180,000
2023-04-12 2023-04-11 PlS Planned sale
3.7
Ianchulev Tsontcho
Non-Executive Director
40,000 -7.1%
4.00
US$160,000 		40,000 -7.1% 4.00 US$160,000
2023-04-03 2023-03-31 PlS Planned sale
3.7
Ianchulev Tsontcho
Non-Executive Director
40,000 -6.7%
3.50
US$140,000 		40,000 -6.7% 3.50 US$140,000
2023-01-03 2022-12-30 B Purchase
2.8
Rowe Michael M

CHIEF EXECUTIVE OFFICER

Executive Director
10,000 +181.8%
1.54
US$15,400 		10,000 +181.8% 1.54 US$15,400
2023-01-03 2022-12-30 B Purchase
3.8
Grant Stuart M.
Large shareholder
21,753 +0.4%
1.50
US$32,630 		21,753 +0.4% 1.50 US$32,630
2022-08-31 2022-08-31 B Purchase
3.0
Strahlman Ellen R
Non-Executive Director
6,686 +18.4%
1.62
US$10,805 		6,686 +18.4% 1.62 US$10,805
2022-08-31 2022-08-30 B Purchase
3.0
Strahlman Ellen R
Non-Executive Director
6,744 +22.8%
1.60
US$10,803 		6,744 +22.8% 1.60 US$10,803
2022-08-31 2022-08-29 B Purchase
3.0
Strahlman Ellen R
Non-Executive Director
7,931 +36.6%
1.62
US$12,838 		7,931 +36.6% 1.62 US$12,838
2022-08-25 2022-08-24 B Purchase
3.0
Strahlman Ellen R
Non-Executive Director
1,504 +7.5%
1.59
US$2,384 		1,504 +7.5% 1.59 US$2,384
2022-06-23 2022-06-21 B Purchase
3.8
Grant Stuart M.
Large shareholder
100,000 +2.0%
1.65
US$165,000 		100,000 +2.0% 1.65 US$165,000
2022-05-23 2022-05-19 B Purchase
1.6
LEE KENNETH B JR
Non-Executive Director
10,000 +30.9%
2.20
US$22,000 		10,000 +30.9% 2.20 US$22,000
2022-05-19 2022-05-18 B Purchase
2.2
MATHER CHARLES E IV
Non-Executive Director
7,000 +16.9%
2.03
US$14,232 		7,000 +16.9% 2.03 US$14,232
2022-05-12 2022-05-11 B Purchase
3.8
Grant Stuart M.
Large shareholder
25,000 +0.5%
1.95
US$48,750 		25,000 +0.5% 1.95 US$48,750
2022-05-12 2022-05-10 B Purchase
3.8
Grant Stuart M.
Large shareholder
50,000 +1.0%
1.98
US$99,000 		50,000 +1.0% 1.98 US$99,000
2022-05-05 2022-05-05 B Purchase
3.8
Grant Stuart M.
Large shareholder
25,926 +0.5%
2.26
US$58,593 		25,926 +0.5% 2.26 US$58,593
2022-05-05 2022-05-04 B Purchase
3.8
Grant Stuart M.
Large shareholder
24,074 +0.5%
2.26
US$54,407 		24,074 +0.5% 2.26 US$54,407
2022-04-25 2022-04-22 B Purchase
3.8
Grant Stuart M.
Large shareholder
20,000 +0.4%
2.55
US$51,000 		20,000 +0.4% 2.55 US$51,000
2022-04-25 2022-04-21 B Purchase
3.8
Grant Stuart M.
Large shareholder
38,800 +0.8%
2.59
US$100,492 		38,800 +0.8% 2.59 US$100,492
2022-02-23 2022-02-22 B Purchase
3.8
Grant Stuart M.
Large shareholder
42,000 +0.9%
2.75
US$115,500 		42,000 +0.9% 2.75 US$115,500
2022-02-23 2022-02-18 B Purchase
3.8
Grant Stuart M.
Large shareholder
10,000 +0.2%
2.85
US$28,500 		10,000 +0.2% 2.85 US$28,500
2022-02-08 2022-02-07 B Purchase
3.8
Grant Stuart M.
Large shareholder
36,030 +0.8%
2.97
US$107,009 		36,030 +0.8% 2.97 US$107,009
2021-12-17 2021-12-15 B Purchase
3.8
Grant Stuart M.
Large shareholder
100,000 +2.2%
3.45
US$345,000 		100,000 +2.2% 3.45 US$345,000
2021-11-17 2021-11-16 B Purchase
3.8
Grant Stuart M.
Large shareholder
25,000 +0.5%
3.52
US$88,000 		25,000 +0.5% 3.52 US$88,000
2021-11-17 2021-11-15 B Purchase
3.8
Grant Stuart M.
Large shareholder
25,000 +0.5%
3.67
US$91,750 		25,000 +0.5% 3.67 US$91,750
2021-11-17 2021-11-15 B Purchase
3.8
Grant Stuart M.
Large shareholder
25,000 +0.5%
3.64
US$91,000 		25,000 +0.5% 3.64 US$91,000
2021-11-17 2021-11-15 B Purchase
3.8
Grant Stuart M.
Large shareholder
25,000 +0.6%
3.60
US$90,000 		25,000 +0.6% 3.60 US$90,000
2021-11-03 2021-11-03 B Purchase
3.7
Ianchulev Tsontcho

CHIEF EXECUTIVE OFFICER

Executive Director
30,000 +5.5%
4.04
US$121,206 		30,000 +5.5% 4.04 US$121,206
2021-11-01 2021-11-01 B Purchase
2.2
MATHER CHARLES E IV
Non-Executive Director
4,000 +15.2%
3.83
US$15,314 		4,000 +15.2% 3.83 US$15,314
2021-11-02 2021-10-29 B Purchase
3.8
Grant Stuart M.
Large shareholder
15,105 +0.3%
3.75
US$56,644 		15,105 +0.3% 3.75 US$56,644
2021-11-02 2021-10-29 B Purchase
3.8
Grant Stuart M.
Large shareholder
400 +0.0%
3.74
US$1,496 		400 +0.0% 3.74 US$1,496
2021-10-27 2021-10-27 B Purchase
2.8
Rowe Michael M

CHIEF OPERATING OFFICER

Officer
1,200 +27.9%
4.14
US$4,968 		1,200 +27.9% 4.14 US$4,968
2021-10-27 2021-10-26 B Purchase
3.8
Grant Stuart M.
Large shareholder
100,000 +2.3%
4.00
US$400,000 		100,000 +2.3% 4.00 US$400,000
2021-10-27 2021-10-25 B Purchase
3.8
Grant Stuart M.
Large shareholder
33,806 +0.8%
4.00
US$135,224 		33,806 +0.8% 4.00 US$135,224
2021-09-13 2021-09-13 B Purchase
2.8
Rowe Michael M

Chief Operating Officer

Officer
1,500 +53.6%
4.40
US$6,600 		1,500 +53.6% 4.40 US$6,600
2021-06-15 2021-06-15 B Purchase
1.6
LEE KENNETH B JR
Non-Executive Director
2,000 +8.6%
5.41
US$10,812 		2,000 +8.6% 5.41 US$10,812
2021-06-15 2021-06-14 B Purchase
1.6
LEE KENNETH B JR
Non-Executive Director
2,000 +9.4%
5.47
US$10,940 		2,000 +9.4% 5.47 US$10,940
2021-06-15 2021-06-11 B Purchase
1.6
LEE KENNETH B JR
Non-Executive Director
2,000 +10.3%
5.38
US$10,760 		2,000 +10.3% 5.38 US$10,760
2021-05-28 2021-05-28 B Purchase
2.2
MATHER CHARLES E IV
Non-Executive Director
3,000 +12.8%
4.76
US$14,268 		3,000 +12.8% 4.76 US$14,268
2021-05-28 2021-05-27 B Purchase
2.8
Rowe Michael M

Chief Operating Officer

Officer
1,400 +100.0%
4.71
US$6,594 		1,400 +100.0% 4.71 US$6,594
Explore more

More insider trading research around Hyperion DeFi Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America